Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stock

Showing results (71-80 of 322) with videos related to

Pageof 33
Sort By:
Leukemia & Lymphoma|February 26, 2014
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplantCamille R Petri, Peter H O'Donnell, Hongyuan Cao, et al.
American Journal of Hematology|January 24, 2023
Sequencing antigen-targeting antibodies and cellular therapies in adults with relapsed/refractory B-cell acute lymphoblastic leukemiaIbrahim Aldoss, Bijal D Shah, Jae H Park, et al.
Blood Advances|July 26, 2021
Self-reported positive impact of mentored clinical research training is associated with academic success in hematologyAllison A King, Sara K Vesely, Grace Dadzie, et al.
Blood Advances|February 26, 2020
Impact of gender and caregiving responsibilities on academic success in hematologyAllison A King, Sara K Vesely, Emily Vettese, et al.
Analytical Biochemistry|October 21, 2005
Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beadsDing Wu, Evan Nair-Gill, Dorie A Sher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell TransplantationAmy Y Wang, Justin Kline, Wendy Stock, et al.
Blood Advances|March 20, 2023
Influence of participant and reviewer characteristics in application scores for a hematology research training programSara K Vesely, Allison King, Emily Vettese, et al.
Investigational New Drugs|January 25, 2008
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemiaOlatoyosi M Odenike, Richard A Larson, Devika Gajria, et al.
Leukemia & Lymphoma|February 16, 2022
MUC4 expression by immunohistochemistry is a specific marker for <i>BCR-ABL1+</i> and <i>BCR-ABL1</i>-like B-lymphoblastic leukemiaBenjamin Kaumeyer, Shiraz Fidai, Madina Sukhanova, et al.
Blood Advances|November 12, 2024
Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adultsXinyue Elyse Zhang, Sharon M Castellino, K Robin Yabroff, et al.
Pageof 33

Showing results (71-80 of 322) with videos related to

Sort By:
Pageof 33
Leukemia & Lymphoma|February 26, 2014
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplantCamille R Petri, Peter H O'Donnell, Hongyuan Cao, et al.
American Journal of Hematology|January 24, 2023
Sequencing antigen-targeting antibodies and cellular therapies in adults with relapsed/refractory B-cell acute lymphoblastic leukemiaIbrahim Aldoss, Bijal D Shah, Jae H Park, et al.
Blood Advances|July 26, 2021
Self-reported positive impact of mentored clinical research training is associated with academic success in hematologyAllison A King, Sara K Vesely, Grace Dadzie, et al.
Blood Advances|February 26, 2020
Impact of gender and caregiving responsibilities on academic success in hematologyAllison A King, Sara K Vesely, Emily Vettese, et al.
Analytical Biochemistry|October 21, 2005
Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beadsDing Wu, Evan Nair-Gill, Dorie A Sher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell TransplantationAmy Y Wang, Justin Kline, Wendy Stock, et al.
Blood Advances|March 20, 2023
Influence of participant and reviewer characteristics in application scores for a hematology research training programSara K Vesely, Allison King, Emily Vettese, et al.
Investigational New Drugs|January 25, 2008
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemiaOlatoyosi M Odenike, Richard A Larson, Devika Gajria, et al.
Leukemia & Lymphoma|February 16, 2022
MUC4 expression by immunohistochemistry is a specific marker for <i>BCR-ABL1+</i> and <i>BCR-ABL1</i>-like B-lymphoblastic leukemiaBenjamin Kaumeyer, Shiraz Fidai, Madina Sukhanova, et al.
Blood Advances|November 12, 2024
Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adultsXinyue Elyse Zhang, Sharon M Castellino, K Robin Yabroff, et al.
Pageof 33